|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Trade accounts receivable, net of allowance for doubtful accounts of $14.3 and $13.1 at June 30, 2023 and December 31, 2022, respectively | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant, and equipment, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and stockholders’ equity | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Short-term financing | ||||||||||||||||||||
| Trade accounts payable | ||||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||||
| Accrued compensation | ||||||||||||||||||||
| Liabilities held for sale | ||||||||||||||||||||
| Other accrued expenses | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Pension and other postretirement benefit liabilities | ||||||||||||||||||||
| Deferred tax liabilities | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Preferred stock, $0.01 par value, 200,000,000 shares authorized, none issued | ||||||||||||||||||||
| Common stock, $0.01 par value, 2,000,000,000 shares authorized, 173,660,528 and 173,237,533 shares issued at June 30, 2023 and December 31, 2022, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock at cost, 5,319,870 and 1,832,385 shares at June 30, 2022 and December 31, 2021, respectively | ||||||||||||||||||||
| Treasury stock at cost, 15,876,417 and 15,254,566 shares at June 30, 2023 and December 31, 2022, respectively | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
| Preferred stock, shares authorized (in shares) | ||||||||||||||||||||
| Preferred stock, par value (usd per share) | ||||||||||||||||||||
| Preferred stock, share issued (in shares) | ||||||||||||||||||||
| Preferred stock, shares outstanding (in shares) | ||||||||||||||||||||
| Common stock, shares authorized (in shares) | ||||||||||||||||||||
| Common stock, shares issued (in shares) |
Loading...
